Aspirin in Heart Attack Prevention: How Much, How Long?
January 15, 2008A low dose of aspirin appears to be just as effective as a higher dose in preventing a heart attack, stroke or death among patients with stable cardiovascular disease, say researchers at Duke University Medical Center.
Scientists also found that taking aspirin as a prevention strategy doubled patients' risk of serious bleeding. Still, they say that for most of the patients, the protective benefits of taking aspirin daily far outweigh risk of any side effects.
"Aspirin is one of the most commonly prescribed drugs in the world and a mainstay in the treatment of heart attack," says Dr. Jeffrey Berger, a cardiologist at the Duke Clinical Research Institute, "but there is still considerable debate over the optimal dose people should be taking on a regular basis to prevent further problems."
The findings appear in the January issue of the American Journal of Medicine.
Berger and his colleagues sifted through 40 years' worth of clinical trials and found only six where researchers could extract data comparing a low dose of aspirin (50 to 325 milligrams) against a placebo in the treatment of patients with previous heart attack, angina or stroke.
In reviewing data from nearly 10, 000 patients enrolled in these trials, researchers discovered that those who took aspirin daily had a 25 per cent reduction in the risk of stroke, a 26 percent reduction in risk of a second heart attack and a 13 percent lower risk of death, when compared with people who took a placebo. Overall, in considering all types of cardiovascular events, patients who took aspirin were 21 percent less likely to encounter potentially fatal problems than those who did not take it.
When the researchers looked more closely at the benefits gained from varying doses, they found no difference between those who were taking only 50 milligrams per day and those who were taking 325 milligrams per day.
They did note, however, that patients taking aspirin were twice as likely to develop serious bleeding as those who did not take it. "One in every 111 people who took low-dose aspirin on a regular basis suffered significant bleeding, so aspirin should be taken with caution," says Berger.
Although many doctors recognize that a lower dose of 81 milligrams of aspirin is just as effective – as well as safer – than a higher dose for the prevention of heart disease, Berger says most doctors are still prescribing 325 milligrams of aspirin at the first sign of a heart attack. "It's just not necessary; that's twice the amount patients really need," he says.
Aspirin helps protect a person from heart attacks because it can break up platelets in the blood that tend to clump together in clots that can block blood vessels and lead to chest pain or heart attack. But aspirin therapy is a two-edged sword: It's that same clot-busting ability that can lead to excess bleeding in some people – bleeding serious enough to warrant transfusion.
"This study tells us several things," says Berger. "First, even though aspirin is relatively cheap and easily obtained as an over-the-counter medication, we need to remember that it is a very powerful drug, even in small doses."
At the same time, Berger says the study may give some clinicians renewed appreciation for a lowly, often overlooked aspirin tablet. "When you put aspirin up against much newer medications like the cholesterol-lowering statins or blood pressure-reducing ACE-inhibitors – which can be very expensive – you see a similar pattern of benefit," he says.
To illustrate, Berger says physicians would need to treat only 71 people with low dose aspirin to prevent a single death, but they would have to treat 83 patients with a statin or 91 patients with an ACE-inhibitor to achieve the same result.
"In these days, when everyone's budget is tight, it's good to know that good prevention strategies do not have to cost a fortune," Berger says.
Berger's work is funded in part from a grant from the American Heart Association.
Source: Duke University Medical Center
-
Easy-to-use blood thinners likely to replace Coumadin
Feb 06, 2012 |
5 / 5 (1) |
0
-
Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding, death
Feb 03, 2012 |
not rated yet |
0
-
Warfarin and aspirin are similar in heart failure treatment
Feb 03, 2012 |
not rated yet |
0
-
Rivaroxaban has less risk of brain bleeding in patients at high risk for stroke
Feb 02, 2012 |
not rated yet |
0
-
Erratic heart rhythm may account for some unexplained strokes
Feb 02, 2012 |
5 / 5 (1) |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (4) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (2) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Botox developer rues missing out on billions
Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.
Medicine & Health / Medications
32 minutes ago |
not rated yet |
0
Many lung cancer patients get radiation therapy that may not prolong their lives
A new study has found that many older lung cancer patients get treatments that may not help them live longer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that p ...
27 minutes ago |
not rated yet |
0
Cancer rate 4 times higher in children with juvenile arthritis
New research reports that incident malignancy among children with juvenile idiopathic arthritis (JIA) is four times higher than in those without the disease. Findings now available in Arthritis & Rheumatism, a journal publis ...
24 minutes ago |
not rated yet |
0
Young adults allowed to stay on parents' health insurance have improved access to care
Researchers from Mount Sinai School of Medicine have found that laws permitting children to stay on their parents' health insurance through age 26 result in improved access to health care compared to states without those ...
17 minutes ago |
not rated yet |
0
Starve a virus, feed a cure? Findings show how some cells protect themselves against HIV
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online ...
14 hours ago |
5 / 5 (3) |
0
|
Japan's Fukushima reactor may be reheating: operator
Temperature readings at one of the crippled Fukushima nuclear reactors have risen above Japan's stringent new safety standard but there was no immediate danger, its operator said Sunday.
Integrated pest management recommendations for the southern pine beetle
The southern pine beetle, Dendroctonus frontalis Zimmermann, is a chronic insect pest within pine forests in the southeastern United States. Under favorable environmental and host conditions, it is an agg ...
AT&T customers surprised by 'unlimited data' limit
(AP) -- Mike Trang likes to use his iPhone 4 as a GPS device, helping him get around in his job. Now and then, his younger cousins get ahold of it, and play some YouTube videos and games.
Australian women reject 'I love u' texts
Australian women may have embraced the digital era, but they prefer a face-to-face declaration of affection to an "I love u" text and find men addicted to their mobile phones a major turnoff.
Scientists discover molecular secrets of 2,000-year-old Chinese herbal remedy
For roughly two thousand years, Chinese herbalists have treated Malaria using a root extract, commonly known as Chang Shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, ...
New method to examine batteries -- MRI from the inside
There is an ever-increasing need for advanced batteries for portable electronics, such as phones, cameras, and music players, but also to power electric vehicles and to facilitate the distribution and storage of energy derived ...